Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (627)	2/17/2000 1:57:00 AM
From: aknahow	Read Replies (1) \| Respond to of 52153

Can any one help me find the rest of this post? PDLI, much less future than xoma, except for ideal future on genomics (like everybody, but AFFX, no products), and at $200 a share the market cap of $3B! (xoma should go 9x6 to $54 following ............(542 more characters) Subject: Biotech Valuation Posted on: Feb 16, 2000 11:11 PM Market caps > $100 million. <<<<BTW xoma site has good description of their humanization technology. XOMA believes that using it in its' own MABS, genimune and ING-1 will provide a demonstration that the technology provides advantages. I am interested in hearing again from anyone that is critical of the XOMA humanization technology. Not to argue, but to understand why one should not put too much faith in it. xoma.com